Bratton Capital Management’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.5M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2025
Q1 | $28.5M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2024
Q4 | $34.9M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2024
Q3 | $48.9M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2024
Q2 | $25.5M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2024
Q1 | $41.8M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2023
Q4 | $19.8M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2023
Q3 | $1.5M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2023
Q2 | $16.2M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2023
Q1 | $11.2M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2022
Q4 | $8.85M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2022
Q3 | $11.5M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2022
Q2 | $6.28M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2022
Q1 | $25.6M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2021
Q4 | $38.2M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2021
Q3 | $42.8M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2021
Q2 | $39M | Hold |
9,810,958
| – | – | 100% | 1 |
|
|
2021
Q1 | $51M | Sell |
9,810,958
-1,692,336
| -15% | -$8.8M | 100% | 1 |
|
|
2020
Q4 | $61.5M | Hold |
11,503,294
| – | – | 100% | 1 |
|
|
2020
Q3 | $55.8M | Hold |
11,503,294
| – | – | 77.67% | 1 |
|
|
2020
Q2 | $55.9M | Hold |
11,503,294
| – | – | 83.77% | 1 |
|
|
2020
Q1 | $25.2M | Hold |
11,503,294
| – | – | 60.15% | 1 |
|
|
2019
Q4 | $66.9M | Hold |
11,503,294
| – | – | 80.13% | 1 |
|
|
2019
Q3 | $36.6M | Hold |
11,503,294
| – | – | 71.47% | 1 |
|
|
2019
Q2 | $48.3M | Hold |
11,503,294
| – | – | 70.95% | 1 |
|
|
2019
Q1 | $79.5M | Hold |
11,503,294
| – | – | 78.22% | 1 |
|
|
2018
Q4 | $72.5M | Buy |
+11,503,294
| New | +$72.5M | 75.94% | 1 |
|